PHARMFLY
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
16-07
Gazette deed
Capital increase of €260,000 to €291,300Auditor report · Amendment of the articles6 points ▸
Gazette deed
Capital increase of €260,000 to €291,300
Auditor report · Amendment of the articles6 points ▸
- General meeting, 26-06-2026
- Other provision, “bijzonder verslag bestuursorgaan, 5:133 Wetboek van Vennootschappen en Verenigingen” (deed in Dutch)
- Auditor report, “inbreng in natura,beschrijving,waarderingsmethodes,tegenprestatie,uitgifte van aandelen, 9700 Oudenaarde,Jacob Lacopstraat 20/207” (deed in Dutch)
- Capital increase, €260,000
- Capital, €291,300
- Amendment of the articles, 5
29-04
micro format · 1 day before the deadline
2025
30-09
Financial
Highest result from 2019 to 2025net €23,116 ▲47.5%
The operating result of €23,492 and the net result of €23,116 are both a record.
14-02
micro format · 75 days before the deadline
2024
29-03
micro format · 32 days before the deadline
2023
31-03
micro format · 30 days before the deadline
2022
30-09
Financial
Back to profitnet €14,853
The net result is €14,853, after 3 loss-making years.
02-05
micro format · 2 days late
2021
30-09
Financial
Weakest financial yearnet -€17,750
The net result drops to -€17,750, the lowest from 2019 to 2025. It recovers the following year.
18-06
micro format · 49 days late
2020
30-04
micro format · on the deadline day
2019
14-05
micro format · 14 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank